Cost Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: Results From the VICTORIA Trial

被引：0
|
作者：
Chew, Derek S. [1 ]
Cowper, Patricia A. [2 ]
Bigelow, Robert [2 ]
Li, Yanhong [2 ]
Anstrom, Kevin [3 ]
Davidson-Ray, Linda D. [3 ]
Hernandez, Adrian F. [3 ]
O'Connor, Christopher M. [4 ]
Armstrong, Paul [5 ]
Mark, Daniel B. [6 ]
机构：
[1] Univ Calgary, Dept Cardiac Sci, Calgary, AB, Canada
[2] Duke Univ, Duke Clin Res Inst, Durham, NC USA
[3] Duke Clin Res Inst, Durham, NC USA
[4] Inova Heart & Vasc Inst, Cardiol, Falls Church, VA USA
[5] Univ Alberta, Dept Cardiol, Edmonton, AB, Canada
[6] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
来源：
CIRCULATION | 2021年 / 144卷 / 25期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17182
引用
收藏
页码：E586 / E586
页数：1
相关论文
共 50 条
  • [41] Population Pharmacokinetics of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: An Integrated Analysis
    Trujillo, Maria E.
    Arrington, Leticia
    Patel, Yogesh
    Passarell, Julie
    Wenning, Larissa
    Blaustein, Robert O.
    Armstrong, Paul W.
    Meyer, Michaela
    Becker, Corina
    Gheyas, Ferdous
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (05) : 1061 - 1069
  • [42] Vericiguat in heart failure with reduced ejection fraction: hope or solid reality?
    Correale, Michele
    Pelaggi, Giuseppe
    Catanoso, Maria Concetta
    Micciche, Serena
    Teresi, Lucio
    Bonanno, Salvatore
    Bellocchi, Paolo
    Poleggi, Cristina
    Capasso, Raffaele
    Barile, Massimo
    Visco, Valeria
    Carluccio, Erberto
    Nodari, Savina
    Ciccarelli, Michele
    Dattilo, Giuseppe
    [J]. HEART FAILURE REVIEWS, 2024, 29 (05) : 1135 - 1143
  • [43] The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
    Aimo, Alberto
    Castiglione, Vincenzo
    Vergaro, Giuseppe
    Panichella, Giorgia
    Senni, Michele
    Lombardi, Carlo Mario
    Emdin, Michele
    [J]. HEART FAILURE REVIEWS, 2022, 27 (04) : 1165 - 1171
  • [44] Changes in natriuretic peptide and effects of vericiguat in worsening heart failure with reduced ejection fraction: Insights from VICTORIA (VerICiguaT Global Study in Subjects with HFrEF)
    Ezekowitz, J.
    Zheng, Y.
    Lund, L.
    Zhang, J.
    Troughton, R.
    Westerhout, C.
    Blaustein, R.
    Butler, J.
    Hernandez, A. F.
    Lam, C. S. P.
    Pieske, B.
    Roessig, L.
    Ponikowski, P.
    O'connor, C. M.
    Armstrong, P. W. Paul Wayne
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 50 - 50
  • [45] Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction
    Parizo, Justin T.
    Goldhaber-Fiebert, Jeremy D.
    Salomon, Joshua A.
    Khush, Kiran K.
    Spertus, John A.
    Heidenreich, Paul A.
    Sandhu, Alexander T.
    [J]. JAMA CARDIOLOGY, 2021, 6 (08) : 926 - 935
  • [46] The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
    Alberto Aimo
    Vincenzo Castiglione
    Giuseppe Vergaro
    Giorgia Panichella
    Michele Senni
    Carlo Mario Lombardi
    Michele Emdin
    [J]. Heart Failure Reviews, 2022, 27 : 1165 - 1171
  • [47] Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction
    Mentz, Robert J.
    Stebbins, Amanda
    Butler, Javed
    Chiang, Chern-En
    Ezekowitz, Justin A.
    Hernandez, Adrian F.
    Hilkert, Robert
    Lam, Carolyn S. P.
    McDonald, Kenneth
    O'Connor, Christopher M.
    Pieske, Burkert
    Ponikowski, Piotr
    Roessig, Lothar
    Sweitzer, Nancy K.
    Voors, Adriaan A.
    Anstrom, Kevin J.
    Armstrong, Paul W.
    [J]. JACC-HEART FAILURE, 2024, 12 (05) : 839 - 846
  • [48] Hemoglobin, anemia, and clinical outcomes in vericiguat global study in subjects with heart failure with reduced ejection fraction (VICTORIA)
    Ezekowitz, J. A.
    Zheng, Y.
    Cohen-Solal, A.
    Melenovsky, V.
    Escobedo, J.
    Butler, J.
    Hernandez, A. F.
    Lam, C. S. P.
    O'Connor, C. M.
    Pieske, B.
    Ponikowski, P.
    Voors, A. A.
    McMullan, C.
    Roessig, L.
    Armstrong, P. W.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 787 - 787
  • [49] Cost-effectiveness of Dapagliflozin in Heart Failure With Reduced Ejection Fraction
    Isaza, Nicolas
    Calvachi, Paola
    Raber, Inbar
    Shen, Changyu
    Gavin, Michael C.
    Garan, A. Reshad
    Bellows, Brandon K.
    Kazi, Dhruv S.
    [J]. CIRCULATION, 2020, 142
  • [50] Age, Sex, and Outcomes in Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial
    Pina, Ileana L.
    Zheng, Yinggan
    Bonderman, Diana
    Pouleur, Anne
    Saldariagga, Clara
    Pieske, Burkert
    Blaustein, Robert O.
    Nkulikiyinka, Richard
    Westerhout, Cynthia M.
    Armstrong, Paul W.
    Lam, Carolyn S.
    [J]. CIRCULATION, 2022, 146
12345